The FDA's proposed heart screen for the first U.S. ibogaine trial would turn away as many as a third of the women who would otherwise qualify. Of 80 public comments, none asks to loosen it.
Regulatory Dispatch, Vol. VI by Odette Hauke. Comments close Nov. 20.
Regulatory Dispatch, Vol. VI by Odette Hauke. Comments close Nov. 20.
0:48